Peripheral Arterial Disease (PAD) Therapeutics Market Report

China Peripheral Arterial Disease (PAD) Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Oct 16, 2023
  • PAGES：229
  • REPORT CODE：GMM1859180
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Peripheral Arterial Disease (PAD) Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck & Co, Inc (US)

    • AstraZeneca Plc (UK)

    • Bristol-Myers Squibb Company (US)

    • Bayer HealthCare Pharmaceuticals (Germany)

    • Symic Bio, Inc (US)

    • Athersys, Inc (US)

    • Multi Gene Vascular Systems Ltd (Israel)

    • ViroMed Co Ltd (Korea)

    • AnGes MG, Inc (Japan)

    • Betagenon AB (Sweden)

    • Proteon Therapeutics, Inc (US)

    • TheraVasc Inc (US)

    By Type:

    • Dual Antiplatelet Therapy Drugs

    • Others

    • Anti-Platelet Drugs

    By Application:

    • Clinics

    • Hospitals

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Peripheral Arterial Disease (PAD) Therapeutics Market Overview 2018-2029

    • 1.1 China Peripheral Arterial Disease (PAD) Therapeutics Industry Development Overview

    • 1.2 China Peripheral Arterial Disease (PAD) Therapeutics Industry Development History

    • 1.3 China Peripheral Arterial Disease (PAD) Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Peripheral Arterial Disease (PAD) Therapeutics Production Volume, Production Value and Growth Rate of Dual Antiplatelet Therapy Drugs (2018-2029)

      • 1.4.2 China Peripheral Arterial Disease (PAD) Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Peripheral Arterial Disease (PAD) Therapeutics Production Volume, Production Value and Growth Rate of Anti-Platelet Drugs (2018-2029)

    • 1.5 China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.2 China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.3 China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis by Region

      • 1.6.1 North China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Peripheral Arterial Disease (PAD) Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Peripheral Arterial Disease (PAD) Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Peripheral Arterial Disease (PAD) Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Peripheral Arterial Disease (PAD) Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Peripheral Arterial Disease (PAD) Therapeutics Industry Development

    Chapter 3 Peripheral Arterial Disease (PAD) TherapeuticsIndustry Chain Analysis

    • 3.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain

    • 3.2 Peripheral Arterial Disease (PAD) Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Peripheral Arterial Disease (PAD) Therapeutics Market

    • 3.3 Peripheral Arterial Disease (PAD) Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Peripheral Arterial Disease (PAD) Therapeutics Market

    Chapter 4 China Peripheral Arterial Disease (PAD) Therapeutics Market, by Type

    • 4.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Peripheral Arterial Disease (PAD) Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Peripheral Arterial Disease (PAD) Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Peripheral Arterial Disease (PAD) Therapeutics Production Volume and Growth Rate of Dual Antiplatelet Therapy Drugs

      • 4.5.2 China Peripheral Arterial Disease (PAD) Therapeutics Production Volume and Growth Rate of Others

      • 4.5.3 China Peripheral Arterial Disease (PAD) Therapeutics Production Volume and Growth Rate of Anti-Platelet Drugs

    Chapter 5 China Peripheral Arterial Disease (PAD) Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Peripheral Arterial Disease (PAD) Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate of Clinics

      • 5.5.2 China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate of Hospitals

      • 5.5.3 China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate of Others

    Chapter 6 China Peripheral Arterial Disease (PAD) Therapeutics Market, by Region

    • 6.1 China Peripheral Arterial Disease (PAD) Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis

    • 7.1 North China Peripheral Arterial Disease (PAD) Therapeutics Market, by Type

    • 7.2 North China Peripheral Arterial Disease (PAD) Therapeutics Market, by Application

    Chapter 8 Central China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis

    • 8.1 Central China Peripheral Arterial Disease (PAD) Therapeutics Market, by Type

    • 8.2 Central China Peripheral Arterial Disease (PAD) Therapeutics Market, by Application

    Chapter 9 South China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis

    • 9.1 South China Peripheral Arterial Disease (PAD) Therapeutics Market, by Type

    • 9.2 South China Peripheral Arterial Disease (PAD) Therapeutics Market, by Application

    Chapter 10 East China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis

    • 10.1 East China Peripheral Arterial Disease (PAD) Therapeutics Market, by Type

    • 10.2 East China Peripheral Arterial Disease (PAD) Therapeutics Market, by Application

    Chapter 11 Northeast China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis

    • 11.1 Northeast China Peripheral Arterial Disease (PAD) Therapeutics Market, by Type

    • 11.2 Northeast China Peripheral Arterial Disease (PAD) Therapeutics Market, by Application

    Chapter 12 Southwest China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis

    • 12.1 Southwest China Peripheral Arterial Disease (PAD) Therapeutics Market, by Type

    • 12.2 Southwest China Peripheral Arterial Disease (PAD) Therapeutics Market, by Application

    Chapter 13 Northwest China Peripheral Arterial Disease (PAD) Therapeutics Market Analysis

    • 13.1 Northwest China Peripheral Arterial Disease (PAD) Therapeutics Market, by Type

    • 13.2 Northwest China Peripheral Arterial Disease (PAD) Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck & Co, Inc (US)

        • 14.1.1 Merck & Co, Inc (US) Company Profile

        • 14.1.2 Merck & Co, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AstraZeneca Plc (UK)

        • 14.2.1 AstraZeneca Plc (UK) Company Profile

        • 14.2.2 AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bristol-Myers Squibb Company (US)

        • 14.3.1 Bristol-Myers Squibb Company (US) Company Profile

        • 14.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bayer HealthCare Pharmaceuticals (Germany)

        • 14.4.1 Bayer HealthCare Pharmaceuticals (Germany) Company Profile

        • 14.4.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Symic Bio, Inc (US)

        • 14.5.1 Symic Bio, Inc (US) Company Profile

        • 14.5.2 Symic Bio, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Athersys, Inc (US)

        • 14.6.1 Athersys, Inc (US) Company Profile

        • 14.6.2 Athersys, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Multi Gene Vascular Systems Ltd (Israel)

        • 14.7.1 Multi Gene Vascular Systems Ltd (Israel) Company Profile

        • 14.7.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 ViroMed Co Ltd (Korea)

        • 14.8.1 ViroMed Co Ltd (Korea) Company Profile

        • 14.8.2 ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 AnGes MG, Inc (Japan)

        • 14.9.1 AnGes MG, Inc (Japan) Company Profile

        • 14.9.2 AnGes MG, Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Betagenon AB (Sweden)

        • 14.10.1 Betagenon AB (Sweden) Company Profile

        • 14.10.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Proteon Therapeutics, Inc (US)

        • 14.11.1 Proteon Therapeutics, Inc (US) Company Profile

        • 14.11.2 Proteon Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 TheraVasc Inc (US)

        • 14.12.1 TheraVasc Inc (US) Company Profile

        • 14.12.2 TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Research Conclusions

    • 15.2 Peripheral Arterial Disease (PAD) Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Industry Market Size (2018-2029)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Production Volume, Production Value and Growth Rate of Dual Antiplatelet Therapy Drugs (2018-2029)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Production Volume, Production Value and Growth Rate of Anti-Platelet Drugs (2018-2029)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Peripheral Arterial Disease (PAD) Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type in 2018

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type in 2023

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Production Volume and Growth Rate of Dual Antiplatelet Therapy Drugs (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Production Volume and Growth Rate of Anti-Platelet Drugs (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2018

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2023

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate of Others (2018-2023)

    • Table China Peripheral Arterial Disease (PAD) Therapeutics Production Volume by Region (2018-2023)

    • Table China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Peripheral Arterial Disease (PAD) Therapeutics Production Value by Region (2018-2023)

    • Table China Peripheral Arterial Disease (PAD) Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Production Value Share by Region (2018-2023)

    • Table China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Region (2018-2023)

    • Table China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Peripheral Arterial Disease (PAD) Therapeutics Sales Value by Region (2018-2023)

    • Table China Peripheral Arterial Disease (PAD) Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Peripheral Arterial Disease (PAD) Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Peripheral Arterial Disease (PAD) Therapeutics Production Volume by Type (2018-2023)

    • Table North China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Peripheral Arterial Disease (PAD) Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Peripheral Arterial Disease (PAD) Therapeutics Production Volume by Type (2018-2023)

    • Table South China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Peripheral Arterial Disease (PAD) Therapeutics Production Volume by Type (2018-2023)

    • Table East China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Peripheral Arterial Disease (PAD) Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Peripheral Arterial Disease (PAD) Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Peripheral Arterial Disease (PAD) Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Peripheral Arterial Disease (PAD) Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Peripheral Arterial Disease (PAD) Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Merck & Co, Inc (US) Company Profile

    • Table Merck & Co, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Plc (UK) Company Profile

    • Table AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company (US) Company Profile

    • Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bayer HealthCare Pharmaceuticals (Germany) Company Profile

    • Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Symic Bio, Inc (US) Company Profile

    • Table Symic Bio, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Athersys, Inc (US) Company Profile

    • Table Athersys, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Multi Gene Vascular Systems Ltd (Israel) Company Profile

    • Table Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table ViroMed Co Ltd (Korea) Company Profile

    • Table ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AnGes MG, Inc (Japan) Company Profile

    • Table AnGes MG, Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Betagenon AB (Sweden) Company Profile

    • Table Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Proteon Therapeutics, Inc (US) Company Profile

    • Table Proteon Therapeutics, Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)

    • Table TheraVasc Inc (US) Company Profile

    • Table TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US